The transient impairments of memory produced by the muscarinic antagonist scopolamine have been adopted as a pharmacological model of Alzheimer-type dementia in normal volunteers. In this study we examined the effects of chronic (72 h) transdermal administration of scopolamine on memory, attention, sedation and visual function. The transdermal patches provided constant plasma levels of scopolamine for the duration of the study. Indices of the peripheral effects of scopolamine (visual near-point and pupil size) showed impairments that were sustained for 3 days. However, measures of sedation and memory revealed impairments that were maximal the day after patch application and which were no longer present 3 days after application. This pattern of results is discussed in relation to pharmacological modelling of Alzheimer's disease.
Get full access to this article
View all access options for this article.
References
1.
Bartus R.T., Dean R.L., Pontecorvo M.J., Flicker C.1985The cholinergic hypothesis: A historical overview, current perspective, and future directionsAnnals of the New York Academy of Sciences, 444: 332-358
2.
Battig W., Montague W.1967Category norms for verbal items in 56 categoriesJournal of Experimental Psychology, Monograph, 80: 3
3.
Bond A.J., Lader M.H.1974The use of analogue scales in rating subjective feelingsBritish Journal of Medical Psychology, 47: 211-218
4.
Broks P., Preston G.C., Traub M., Poppleton P., Ward C., Stahl S.M.1988Modelling dementia: effects of scopolamine on memory and attentionNeuropsychologia26: 685-700
5.
Buschke H.1973Selective reminding for analysis of memory and learningJournal of Verbal Learning and Verbal Behaviour12: 543-550.
6.
Citron N.M., Chen Y-M.1987A sensitive radioreceptor assay for determining scopolamine concentrations in plasma and urineJournal of Pharmaceutical Sciences76: 328-332
7.
File S.E., Lister R.G.1983Does tolerance to lorazepam develop with once weekly dosing?British Journal of Climcal Pharmacology16: 645-650
8.
Flowers K.1975Ballistic and corrective movements on an aiming taskNeurology25: 413-421
9.
Graybiel A., Cramer D.B., Wood C.D.1982Antimotion-sickness efficacy of scopolamine 12 and 72 hours after transdermal administrationAviation Space and Environmental Medicine53: 770-772
10.
Homick J.L., Lee Kohl R., Reschke M.F., Degionanni J.Citron-Trevino N.M.1983Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course for efficacyAviation Space and Environmental Medicine54: 994-1000
11.
Hordinsky JR, Schwartz E., Beier J., Martin J.Aust G.1982Relative efficacy of the proposed space shuttle antimotion-sickness medicationsActa Astronautica9: 375-383
12.
Milner B.1971Interhemispheric differences in the localization of psychological processes in manBritish Medical Bulletin27: 272-277
13.
Neuchterlein K.H., Parasuraman R., Qiyuan J.1983Visual sustained attention: image degradation produces rapid sensitivity decrements over timeScience220327-329
14.
Parrott A.C.1986a The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performancePsychopharmacology89: 347-354
15.
Parrott A.C.1986b Transdermal scopolamine: effects of single and repeated patches upon aspects of visionHuman Psychopharmacology1: 109-115.
16.
Parrott AC1987Transdermal scopolamine: effects of single and repeated patches upon psychological task performanceNeuropsychobiology17: 53-59.
17.
Parrott A.C.Jones R.1985Effects of transdermal scopolamine upon psychological test performance at sea. EuropeanJournal of Clinical Pharmacology28: 419-423.
18.
Preston G.C., Broks P., Traub M., Ward C., Poppleton P., Stahl S.M.1988a Effects of lorazepam on memory, attention and sedation in manPsychopharmacology95: 208-215.
19.
Preston G.C., Brazell C., Ward C., Broks P., Traub M., Stahl S.M.1988b The scopolamine model of dementia: determination of central cholinomimetic effects of physostigmine on cognition and biochemical markers in manJournal of Psychopharmacology2: 67-79.
20.
Preston G.C., Ward C., Broks P., Traub M., Stahl S.M.1989Effects of lorazepam on memory, attention and sedation in man: antagonism by Ro 15-1788Psychopharmacology96: 145-152.
21.
Rusted J.M., Warburton D.M.1988The effects of scopolamine on working memory in healthy young volunteersPsychopharmacology96: 145-152.
22.
Wilkins A.J., Robson J.G.Cambridge Low Contrast GratingsClement Clarke International Ltd., London
